RubrYc Therapeutics announces a research collaboration and license option agreement with Zai Labs

RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the …